Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Thanks to all who help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Yet Again, Johnson & Johnson Uses Deceptive Marketing to Increase Sales
Would Johnson & Johnson be able to make any money without lying, falsifying or misleading consumers about the size, safety and effectiveness of their products?

Keywords: deceptive, marketing, fraud, misleading, consumers, packaging, fraudulent, package
Date Created/Edited: 2015, January 19
 

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
My first article for the new year is just another product with the same old theme: Johnson & Johnson yet again used deceptive marketing practices to get more money out of consumers. The consequences for yet again ripping off consumers: JNJ was fined an absolutely pathetic $506,000. Amazingly, the current CEO of JNJ Alex Gorsky could pay this off with literally 10 days of his 2014 salary and benefits of almost $17 million. Not much of a fine, eh? Thankfully, it wasn't another harmful drug or device causing permanent injuries, disability and even death and everything in between, it was consumer goods. This time, the strategy used was false bottoms and sides to give the impression that the product was a better value than comparable products from other brands.
 
JNJ got a pathetic little fine and 2 *years* to recreate packaging material that is not deceptive regarding the volume of the product. Two more years of deceiving customers, not only in California, but across the country, and likely around the world. I think a better option would have been fine them *and* have them remove all products with misleading packaging until the products were packaged without deceit.
 

As consumers, we need to let them know exactly how we feel by choosing to purchase fairly marketing products from other companies - preferably your local natural store. The loss of revenue from consumer goods sales will likely have a far greater impact on their choice to abide by the rules than a pathetic fine and a whisper of negative publicity.
 
No stranger to false, deceptive and fraudulent marketing strategies, this latest scheme ranks right up there with Xarelto, Risperdal, metal-on-metal hips, Medicaid fraud, vaginal mesh and a whole slew of other products. All marketed fraudulently, all promising something they did not deliver and many harmful; some even downright deadly.
 
Would Johnson & Johnson be able to make any money without lying, falsifying or misleading consumers about the size, safety and effectiveness of their products?
 

 
Resources:
1. Corin Hoggard (2014, December 30). Johnson & Johnson accused of misleading consumers ABC 7 Chicago. Retrieved from http://abc7chicago.com/news/johnson-and%20johnson-accused-of-misleading-consumers/456130/
 
2. Emily Patterson (2014, September 14). Johnson & Johnson Xarelto, False Marketing, Lawsuits and FDA Says THREE TIMES, "NO EXPANDED USES!" Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/xarelto_continued.shtml
 
3. Emily Patterson (2013, June 20). Johnson & Johnson Defense Against $1.2 Billion Arkansas Risperdal: We Have a Constitutional Right to Lie Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/right_to_lie.shtml
 
4. Emily Patterson (2013, May 17). DePuy Metal on Metal Hips Dropped by Johnson & Johnson Due to Lack of Sales, Not Lack of Safety, WTF? Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mom_hips.shtml
 
5. Emily Patterson (2014, March 20). On Repeal Judges Ignore Jury and Give Johnson & Johnson Thumbs Up to Harm Children and Elderly and Steal from Medicaid Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal_arkansas_reversal.shtml
 
6. Emily Patterson (2041, March 2). Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mesh_document_destruction.shtml
 
7. Emily Patterson (2013, May 6). Will YOU Use Johnson & Johnson Sedation Device? Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_sedation_device.shtml
 
 
 
 
 
 
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries